The 14 most recent market catalysts affecting $BBWI, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 10, 2026
Corporate Catalyst
Neutral
Impact 85
'Barington Takes New Stake in Bath & Body Works, Pushing for Sale' - Bloomberg News
Activist investor Barington Capital Group has taken a new stake in Bath & Body Works and is publicly pushing for the company to explore a sale. This is a significant corporate cata…
Sep 9, 2026
Corporate Catalyst
Neutral
Impact 55
BMO Capital Initiates Coverage On Bath & Body Works with Market Perform Rating, Announces Price Target of $20
BMO Capital's initiation of coverage on Bath & Body Works (BBWI) with a 'Market Perform' rating and a $20 price target provides a new analytical perspective on the company. While n…
Aug 27, 2026
Corporate Catalyst
Bearish
Impact 55
Baird Maintains Neutral on Bath & Body Works, Lowers Price Target to $23
Baird analyst Mark Altschwager maintained a 'Neutral' rating on Bath & Body Works (BBWI) but lowered the price target from $25 to $23. This action signals a slightly diminished val…
Aug 27, 2026
Corporate Catalyst
Bearish
Impact 75
These Analysts Slash Their Forecasts On Bath & Body Works Following Q2 Results
Bath & Body Works (BBWI) announced Q2 results that surpassed analyst expectations for both adjusted earnings and net sales, and also raised its fiscal 2026 GAAP and adjusted earnin…
Aug 26, 2026
Corporate Catalyst
Bullish
Impact 85
Bath & Body Works Says ‘You Can’t Promote a Business Back to Health’
Bath & Body Works (BBWI) delivered a positive surprise in its Q2 2026 earnings, exceeding analyst expectations for both EPS and sales. A substantial $80 million tariff refund signi…
Aug 26, 2026
Corporate Catalyst
Bullish
Impact 85
Bath & Body Works shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 EPS guidance.
The headline indicates a significant positive corporate catalyst for Bath & Body Works (BBWI). Better-than-expected Q2 results and raised FY26 EPS guidance signal strong underlying…
Aug 26, 2026
Corporate Catalyst
Bearish
Impact 95
Bath & Body Works Sees Q3 Adj EPS $0.07-$0.12 vs $0.26 Est; Lowers Q3 Sales Guidance from $1.634B-$1.674B to $1.514B-$1.554B vs $1.548B Est
Bath & Body Works (BBWI) filed an 8-K disclosing a significant reduction in its Q3 sales guidance and an adjusted EPS forecast that is substantially lower than analyst estimates. T…
Aug 26, 2026
Corporate Catalyst
Bearish
Impact 75
Bath & Body Works Narrows 2026 Sales Decline To 4%-2.5%, Raises EPS Outlook, Forecasts $650M Free Cash Flow And Sees Q3 Sales Down 5%-2.5%
Bath & Body Works (BBWI) has provided an updated financial outlook for fiscal year 2026 and Q3 2026. The company narrowed its full-year 2026 net sales decline projection, which is …
Aug 26, 2026
Corporate Catalyst
Bullish
Impact 75
Bath & Body Works Raises FY2026 GAAP EPS Guidance from $3.00-$3.25 to $3.13-$3.33 vs $2.86 Est
Bath & Body Works (BBWI) announced an upward revision to its FY2026 GAAP EPS guidance, moving the range from $3.00-$3.25 to $3.13-$3.33. This is a significant development as the ne…
Aug 26, 2026
Corporate Catalyst
Bullish
Impact 92
Bath & Body Works Q2 Adj. EPS $0.62 Beats $0.24 Estimate, Sales $1.514B Beat $1.497B Estimate
Bath & Body Works (BBWI) announced Q2 adjusted EPS of $0.62, significantly beating the $0.24 estimate, and sales of $1.514 billion, also surpassing the $1.497 billion estimate. Thi…
Aug 26, 2026
Corporate Catalyst
Neutral
Impact 75
Bath & Body Works Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Bath & Body Works (BBWI) is approaching its Q2 earnings release, a significant corporate catalyst for the stock. Analysts are projecting a year-over-year decline in both earnings p…
Aug 18, 2026
Corporate Catalyst
Bullish
Impact 75
Bath & Body Works shares are trading higher after Citigroup upgraded its rating on the stock from Neutral to Buy and maintained its $25 price target. Also, JP Morgan maintained its Neutral rating and raised its price target from $22 to $24.
This headline represents a significant corporate catalyst for Bath & Body Works. Citigroup's upgrade from Neutral to Buy, coupled with JP Morgan's raised price target, indicates a …
Aug 18, 2026
Corporate Catalyst
Bullish
Impact 55
JP Morgan Maintains Neutral on Bath & Body Works, Raises Price Target to $24
This 8-K filing discloses that JP Morgan analyst Matthew Boss has maintained a 'Neutral' rating on Bath & Body Works (BBWI) but has raised the price target from $22 to $24. This in…
Aug 18, 2026
Corporate Catalyst
Bullish
Impact 65
Citigroup Upgrades Bath & Body Works to Buy, Maintains Price Target to $25
Citigroup analyst Paul Lejuez upgraded Bath & Body Works (BBWI) from a 'Neutral' to a 'Buy' rating, while maintaining the price target at $25. This upgrade indicates a more optimis…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.